TY - JOUR
T1 - Early Histopathology In Oral Submucous Fibrosis (OSF) To Rule The Possibility Of Epithelial Dysplasia - Report Of Two Cases
AU - Wati, Sisca Meida
AU - Banerjee, Abhishek
AU - Chatterjee, Abhishek
AU - Chatterjee, Kumarjyoti
AU - Rahayu, Retno Pudji
AU - Budhy, Theresia Indah
N1 - Publisher Copyright:
© 2022 Wolters Kluwer Medknow Publications. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Oral submucous fibrosis (OSF) is a chronic scarring and progressive condition affecting the oral cavity, oropharynx and upper portion (1/3rd) of the esophagus. It is a potentially malignant disorder. It usually presents with trismus as the chronicity progresses with a pal presentation of the mucosa. Encountering a whitish patch, ulcer or a growth in the bed of Oral submucous fibrosis is something thought provoking. The malignant transformation potential of Oral submucous fibrosis is comparatively higher than other premalignant conditions affecting oral cavity. The need for biopsy at any stage of OSF is a necessity to rule out underlying pathogenicity to transform towards malignancy or dysplasia.
AB - Oral submucous fibrosis (OSF) is a chronic scarring and progressive condition affecting the oral cavity, oropharynx and upper portion (1/3rd) of the esophagus. It is a potentially malignant disorder. It usually presents with trismus as the chronicity progresses with a pal presentation of the mucosa. Encountering a whitish patch, ulcer or a growth in the bed of Oral submucous fibrosis is something thought provoking. The malignant transformation potential of Oral submucous fibrosis is comparatively higher than other premalignant conditions affecting oral cavity. The need for biopsy at any stage of OSF is a necessity to rule out underlying pathogenicity to transform towards malignancy or dysplasia.
KW - dysplasia in OSF
KW - malignant lesion
KW - oral submucous fibrosis
UR - http://www.scopus.com/inward/record.url?scp=85143279936&partnerID=8YFLogxK
U2 - 10.47750/pnr.2022.13.S05.56
DO - 10.47750/pnr.2022.13.S05.56
M3 - Article
AN - SCOPUS:85143279936
SN - 0976-9234
VL - 13
SP - 387
EP - 390
JO - Journal of Pharmaceutical Negative Results
JF - Journal of Pharmaceutical Negative Results
ER -